Advertisement
U.S. Markets open in 3 hrs 10 mins
S&P Futures
5,898.50 -21.50 (-0.36%) Dow Futures
43,312.00 -228.00 (-0.52%) Nasdaq Futures
20,580.75 -52.75 (-0.26%) Russell 2000 Futures
2,293.90 -23.80 (-1.03%) Crude Oil
68.84 -0.32 (-0.46%) Gold
2,638.90 +24.30 (+0.93%)
Celyad Oncology SA (CLYYF)
OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Follow
At close: 03:00PM EST
| Previous Close | 0.0000 |
| Open | 0.3580 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.3150 - 0.3150 |
| 52 Week Range | 0.2450 - 0.7377 |
| Volume | |
| Avg. Volume | 7 |
| Market Cap | 29.88M |
| Beta (5Y Monthly) | 1.47 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.4300 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Business WireCelyad Oncology to Present at the 2024 SITC Annual Meeting
MONT-SAINT-GUIBERT, Belgium, October 07, 2024--Regulatory News: Celyad Oncology (Euronext: CYAD) (the "Company"), today announces two poster presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held in Houston, November 6-10, 2024.
Business WireCelyad Oncology Announces Appointment of Matt Kane as Chief Executive Officer
MONT-SAINT-GUIBERT, Belgium, September 16, 2024--Regulatory News: Celyad Oncology (Euronext: CYAD) (the "Company" or "Celyad") is pleased to announce Matt Kane as its new Chief Executive Officer (CEO), effective as of October 1st, 2024.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.